poster presentation in conference 2023

Poster Preparation Instructions

General considerations.

Plan to arrive 10 minutes before the session is to begin. The Annual Meeting Program will indicate the monitor number to which you have been assigned. The presenting author should be available throughout the session and be prepared to vacate the monitor no more than 10 minutes after the end of the session. The digital poster that presenters create in the AERA i-Presentation Gallery should be as self-explanatory as possible so that your main job is to supplement the information it contains. The i-Presentation format provides a mechanism for in-depth discussion of your research, but this is possible only if the display includes enough information to engage viewers. It is also strongly recommended that the author have available copies (about 20) of the full paper to distribute to interested parties.

In-person poster session presenters will present and discuss their posters on large-format touchscreen monitors in Chicago, in scheduled sessions to be held in the area dedicated to poster sessions. Poster presenters simply access their presentations from the i-Presentation Gallery to show their work with the dynamic features that electronic monitors provide.

Virtual poster session presenters will have their presentations available in the i-Presentation Gallery no later than the start of the virtual component of the Annual Meeting on May 4. Authors of papers accepted as virtual posters should use the pre-recorded functions to engage attendees in their work. Virtual attendees will be encouraged to visit the Gallery on May 4 and May 5—at a time when they can take the time to benefit from viewing work of interest to them and network with authors.

​ Arrangement of Materials

The AERA i-Presentation Gallery provides Annual Meeting poster presenters a user-friendly, multimedia vehicle to present their papers in a dynamic format that allows for an overall narration as well as audio or video capture within any slide as part of their display. The paper title and the authors' name and affiliations should appear at the top of the digital poster. Text and illustrations should be legible. Figures and tables should be kept as simple as possible, so that viewers can readily take away the main message.  A copy of your abstract (300 words or less) should be placed in the upper left portion of the poster, with a conclusion in the lower right-hand corner. Although there is considerable room for flexibility, it is often useful to have panels indicating the aims of the research, the methods and subjects involved, and the experimental tasks. Another panel might highlight the important results, with a few panels being used to present the main points in tables or figures.   When working on the arrangement of your display on the poster, be aware that viewers who are scanning posters have a much easier task if they can proceed from the left to right rather than having to skip around in the display.

Check out the i-Presentation author resources page, provided by aMuze! Interactive. It includes helpful tutorials, quick guide, FAQs, and sample presentations. AERA will provide virtual training sessions prior to the Annual Meeting.

Additional Presentation Guidelines

AERA strongly urges all who create a presentation in the i-Presentation Gallery to create an overall narration and upload it as part of their presentation so that visitors to the Gallery can benefit from a pre-recorded overview of the work (more than one author can participate in the pre-recording). These can be short but are important for sparking Gallery attendees’ interest in the research presented.

SLAS2023 Poster Presentation Guidelines

February 25 - March 1, 2023

San Diego, CA, USA

Presenting a poster at SLAS2023 is an effective way for attendees to hype up their research. Each presentation session is attended by leading researchers, academics, technology and industry professionals and can lead to future collaboration opportunities. Poster presentations are often the “presentation method of choice” for many scientists.

To be considered for a poster presentation, submit an abstract for consideration via the deadlines and guidelines below. Space is limited!

Deadlines for Submission

Tony B. Academic Travel Award Poster Submissions Due:

Monday, October 17

Poster Abstract Submissions Due:

Monday, October 17 (Deadline for inclusion in Student Poster Competition)

Wednesday, February 8, 2023 (Final Poster Abstract Submission Deadline)

Poster Abstract Decisions Communicated:

Beginning of November 2022 (On a monthly basis thereafter through Final Deadline.)

Please note that a schedule of poster presentations will be available via the SLAS Event Scheduler in late-November 2022.

Submit a Poster Abstract

Poster Presentation Guidelines

Poster Presentations Sessions are scheduled for Sunday, February 26, Monday, February 27 and Tuesday, February 28 in the SLAS2023 Exhibition Hall at the times shown below. Posters may be displayed for the duration of exhibition hours on Monday, Tuesday and Wednesday. Poster presenters will be assigned a poster presentation number and presentation date upon acceptance of their submitted abstract.

Presenters must be present for the duration of their scheduled poster presentation session to “present” their poster content. However, SLAS encourages poster presenters to display their posters for the duration of exhibit hall hours on all three exhibition dates.

• Poster Set-Up: Morning of Sunday, February 26 (exact time TBD)

Sunday, February 26

• 11:30 a.m. – 12:30 p.m.
• 2:30 – 3:30 p.m.
• 5:30 – 6:30 p.m.

Monday, February 27

Tuesday, February 28

• Poster Tear-Down (Tentative): Any time after 12:30 p.m. on Tuesday, February 28 No later than 1:00 p.m. on Tuesday, February 28

Attendance Requirements for Poster Presenters

• All presenters must be registered as full-conference attendees in order to present at SLAS2023. If the primary author is not available during the scheduled presentation time, a co-author may present the poster instead.
• It is REQUIRED that a presenter be stationed at the poster for the duration of the poster presentation session (on the assigned date of presentation).

Poster Board Guidelines

Poster dimensions:.

Poster size may not exceed 3 feet 7 inches [109 cm] across and 3 feet, 6 inches [107 cm] high.

Each board will be numbered on the upper left corner. Be sure you place your presentation on the board number for which you have been assigned. If you do not know your poster assignment number, please refer to the Conference Final Program. Note that you will be sharing a poster board with another presenter; there will be two posters displayed per board.

Posters not printed according to the specifications above will be removed and discarded.

Pushpins will be available to mount your poster. Handouts are encouraged as is a mechanism (envelope) for collecting contact information of participants wishing to receive more information on your poster. Envelopes will NOT be available and you may not encroach on your boardmate’s space with your supplemental materials.

NOTE: There will NOT be a table underneath the poster board.

Scientific posters should be prepared in accordance with ACS Style Guidelines

Poster Board Design:

• Title Banner: Lettering should be at least 3/4 [1.9 cm] to 1 inch [2.5 cm] high (72 pt. bold). The banner should include the author(s) and affiliation(s).
• Font: Use a sans serif font such as Arial or Helvetica in a minimum size of 24 pt. (1/4 inch high). Text, figures and photographs should be readable from a distance of 4 feet.
• Bullets and Numbering: Be simple and direct in your poster presentation. Use short phrases and "bulleted" text throughout the poster. Avoid long narrative paragraphs.

Poster Board Layout:

Arrange the poster for logical flow top left to lower right. The panels may be numbered in the order they should be viewed or you may use chart pak colored tape to guide the viewer.

Poster Board Content:

The poster should include the following elements:

• Overview: A succinct summary of the purpose, methods, and results. Use phrases rather than sentences in a simple outline format.
• Introduction: A concise statement of the objective and background of the work.
• Methods: Describe the apparatus, chemistry, samples, and materials used in detail.
• Results: Use graphs, spectra, charts, and pictures with a minimum of text to illustrate results.
• Conclusions: Concise statement of the findings indicating future research directions.

NOTE: Poster presentation may not be used as a sales or marketing opportunity. No hardware, books, accessories, or saleable items may be displayed at a poster.

Poster Numbers and Arrangement Onsite

Poster presenters are encouraged to display their posters for the duration of the exhibition hours at SLAS2023, but presenters are required to be available to present their poster content based on their scheduled presentation date and time. Presenters will be assigned to one of the following five poster presentation sessions (times are tentative):

• Poster Presentation Session A: Sunday, February 26, 11:30 a.m. – 12:30 p.m.
• Poster Presentation Session B: Sunday, February 26, 2:30 – 3:30 p.m.
• Poster Presentation Session C: Sunday, February 26, 5:30 – 6:30 p.m.
• Poster Presentation Session D: Monday, February 27, 11:30 – 12:30 p.m.
• Poster Presentation Session E: Monday, February 27, 2:30 – 3:30 p.m.
• Poster Presentation Session F: Tuesday, February 28, 11:30 a.m. – 12:30 p.m.

Posters will be displayed in clusters throughout the SLAS2023 exhibition floor. Poster numbers are color coded by track and include a unique four digit presentation number. Presentation date and numbers will be distributed on a rolling/monthly basis between November and January upon review/acceptance by the SLAS2023 Scientific Program Committee.

Poster printing at the San Diego Convention and Exhibition Center will be available. More information to be posted soon.

2023 IEEE International symposium on antennas and propagation

30th October to 2nd November 2023 @ Kuala Lumpur, Malaysia

Poster Presentation Guidelines

The poster with A0 size and must be mounted in portrait orientation. This means that the poster should not be wider than 841 mm, and not higher than 1189 mm.

The title should be the same as in the submitted abstract. Include the title of your presentation at the top of the poster.

Poster Organization

There is no specific template for the poster layout. Authors are free to use their own design. However, you are advised to divide your poster into sections such as Introduction, Objectives, Methods, Results, Discussion, Conclusions and references.

You might consider organizing your poster around the following questions: • What problem do you address? (Objectives) • Why is this problem important? (Background) • How did you address the problem? (Methods) • What did you discover as a result of your work? (Results) • What are the conclusions or greater implications of your work? (Discussion and conclusions)

We recommended all participant to used the ISAP 2023 poster template as given:

POSTERS ARE REQUIRED TO BE DISPLAYED THROUGHOUT THE CONFERENCE

Posters representing authors are required to be available for presentation during the scheduled poster sessions.

ITiCSE 2023

Welcome to Turku Finland

Call for posters

This page provides detailed information about poster submissions to the ITiCSE 2023 conference. It is part of the general  Call for Participation  which you should read first, if you have not yet done so.

If you have questions that neither this page nor the  Call for Participation  can answer, please  contact the poster chairs .

Poster presentation

ITiCSE poster sessions provide an opportunity to share computing education ideas in a less formal setting than a paper presentation.

A poster is a single-page document, typically combining text and images, that embodies a succinct description of work that has been done. Presenting a poster is a good way to discuss and receive feedback on a work in progress that has not been fully developed into a paper.

Posters should not re-present previously published work.

Poster proposal review is not anonymous.

ITiCSE 2023 will be held face to face and all presenters will be required to present their poster in person during a dedicated time slot. More information will be made available in due course.

By SIGCSE Organization policy, at least one author is required to register, attend and present the poster. See our full policy for more information.

Poster topic ideas

The topic of a poster presentation is not limited. However, the topic should lend itself to presentation in poster format, possibly with additional details available in the form of web references. You might consider a poster presentation of teaching materials that you would like to share, or preliminary research findings. Examples might include

• imaginative assignments
• innovative curriculum design
• laboratory materials
• effective ideas for recruiting and retaining students
• computing education research that is in a preliminary stage

Suggestions for poster design are given in Research Posters 101 . Although these suggestions were published for student researchers, the ideas are also applicable to posters for this conference.

Formatting the poster proposal

A poster proposal is a single page, in PDF format, explaining what the poster is about. The proposal is used for the review process, and, if the proposal is accepted, for publication in the ITiCSE proceedings. The one-page proposal must adhere to ACM’s publication guidelines. For more detail, see Formatting requirements on the Call for Participation page .

Poster proposal contents

A poster proposal will typically include the following information.

• Title: a title for the poster.
• Proposer: include name, affiliation, and email address. Correspondence related to the conference will be sent by email. Please check your spam filter if you haven’t received an expected notification because the bulk emails generated by the conference software are sometimes blocked.
• Abstract: a description of the poster. The same abstract will also need to be copied into a text box on the submission page. Please be sure that your description is accurate and that both submitted copies (in the PDF poster proposal and in the submission text box) are exactly the same.
• Content: A description of the expected content of the poster, along with an indication of why the topic is significant: why conference attendees will find it interesting.

Important dates for posters

Important dates can be found in the sidebar on the right.

Submitting a poster proposal

Write your submission using the format specified above.

Convert your paper into Adobe PDF format.

Follow the instructions on Submission process at the foot of the Call for Participation page.

If you have questions about anything discussed above, please contact the poster chairs .

We use cookies to offer you a better browsing experience, "recognize" returning AAAL members, and analyze site traffic. By using the site, you consent to our use of cookies. To withdraw consent, please adjust your cookie settings in your browser.

Presenter Resources

Presenter guidelines.

To help you prepare for your presentation, our team has put together detailed guidelines for each presentation type:

Instructions for  poster presentations,  click here:                          Click Here to View

Instructions for  individual paper presentations, click here:        CLICK HERE TO VIEW

Instructions for  roundtable presentations, click here:                 Click Here to View

Instructions for  colloquium presentations,  click here:                 Click Here to View

Searchable Schedule

To view our Searchable Schedule and find the time of your presentation, click here . 

Technological Requirements

To access information about the technological requirements for presenters, click here .

Hotel Floor Plan

To view a diagram of the Portland Marriott Downtown Waterfront Hotel, click here .

>>> Return to AAAL 2023 Conference Home

Membership & Account Access

Are you already a member or do you want to create a guest account .

If you are already a member of AAAL or you would like to create a guest account, start by setting up your login information by clicking "Create An Account".

This option is also for current members of AAAL who need to login.

Are you ready to join AAAL?

We offer a variety of membership categories to serve the field of applied linguistics.

2023 Annual Conference Poster Presentations Available for Viewing

  View poster content from the 2023 AAACN Annual Conference.

Select the title of the poster you wish to view. Complementary recordings from poster presenters available where listed.

#RSCPoster is a free global online poster conference held on LinkedIn over the course of 24 hours

The event brings together the global chemistry community to  network  with colleagues across the world and at every career stage,  share  their research and  engage  in scientific debate.

We want #RSCPoster to be an inclusive event, connecting researchers from around the world to share and discuss their work. While #RSCPoster takes place on LinkedIn, we are happy for participants to cross-post their posters to engage in discussion with members of the community that use other social media platforms. Prizes will only be awarded based on participation on LinkedIn, so you must share your poster on the platform to be eligible.

About #RSCPoster

#RSCPoster has moved to LinkedIn! Follow our main RSC account and our subject category pages for updates on how to get involved and to keep up to date with our journal activities.

Subject categories

You can also find additional journals on linkedin:, explore the 2024 winners.

Competition was high with the successful launch of #RSCPoster on LinkedIn.

How it works and FAQs

Organisers, subject chairs and general committee, related events and webinars, rsc poster journal collection now available.

The RSC Poster Journal Collection showcasing research presented at the #RSCPoster conference in 2023 is now available.

Sponsors and support

Thank you to our sponsors for supporting #RSCPoster 2024.

Why not enter #RSCposter 2025?

• no registration fees
• participate from anywhere with LinkedIn access
• meet researchers from all over the world, at every career stage
• spend as little or as much time attending as you like
• cash and community prizes for the best posters as judged by our excellent Committees
• community prize for the best #RSCPosterPitch as selected by our General Committee

Browse all events

Contact the organisers.

• Annual Meeting

• Generation Public Health
• Public Health Thank You Day
• Who is public health?
• Climate, Health and Equity
• Racial Equity
• Environmental Health
• Gun Violence
• Health Equity
• All Topics and Issues
• Advocacy for Public Health
• Policy Statements
• American Journal of Public Health
• The Nation's Health
• Fact Sheets
• Reports and Issue Briefs
• Advertising
• Public Health Buyers Guide
• Publications Contacts
• Continuing Education
• Public Health CareerMart
• Internships & Fellowships
• Careers at APHA
• National Public Health Week
• Policy Action Institute
• APHA Calendar
• News Releases
• Social Media
• Brand Guidelines
• Member Sections
• Student Assembly
• Member Perks
• Membership Rates
• Agency Membership
• School-Sponsored Student Membership
• Special Member Savings
• Early-Career Professionals
• Gift Membership
• APHA Your Way
• Member Directory
• Events & Meetings >
• Annual Meeting >
• Presenters >

Poster Session Guidelines

• Events & Meetings

Attention:  All Annual Meeting presenters who submitted abstracts for oral, poster or roundtable sessions must be in Atlanta to present. There are no virtual options for presenters.

A Poster Session is a graphic presentation of an author's research. Authors illustrate their findings by displaying graphs, photos, diagrams and a small amount of text on the poster boards. Poster Sessions will take place in the Public Health Expo. Authors will hold discussions with attendees who are circulating among the poster boards.

General Information

• Poster presenters must be individual members of APHA and they must register for the meeting.
• Poster sessions are one hour long. During the session you will remain by your poster board and share your research with other attendees.
• Your poster is part of a session consisting of 10 posters. Your 4-digit session number and board number can be found in the online program . When you arrive, find your session number on the sign in front of the row and then locate your board number.
• Posters may be set up 30 minutes before the start of the session.
• Presentations should be taken down within 30 minutes after the session ends. Display materials not removed following the conclusion of the session will be discarded.
• No audiovisual equipment is permitted for poster presentations.
• Push pins will be available on-site for mounting the displays. 
• A chair will be provided for each Poster Session presenter.

Poster Development Tips

• Posters must fit on mounted stands that are 4 feet tall by 8 feet wide. See some recommended poster sizes .
• Keep accessibility in mind when designing your poster. Checkout our guidelines for accessible presentations .
• The material should be well labeled and legible from a distance of 10 to 15 feet away. Lettering should be bold. Use a large sans serif font such as Veranda.
• Consider the Better Research Poster design for an easy-to-digest poster design.

Posters Printed, Laminated and Ready for Pickup

There is no need to struggle through airport security with bulky poster carrying cases, pay for an extra carry-on or to take the chance that your hard work and research will be lost/misplaced during your travels. Send your files digitally and pick up your poster on-site at the APHA Poster Distribution Desk . Once your presentation is finished, return your poster to the pickup desk for recycling, or we can ship it anywhere in the contiguous U.S. for $40. Order from Research-Posters by Sunday, Sept. 10 for the best rates.  Use EARLYBIRD promo code.

Otherwise, order by Sunday, Oct. 29 (last day for guaranteed delivery). Use APHADISC promo code.

For orders AFTER Sunday, Oct. 29: These MAY be accepted on a case-by-case basis by sending an email to [email protected] along with your PDF file and presentation date & time for availability and pricing. The Poster Distribution Desk will be conveniently located within the APHA Expo Hall, near the poster boards.

Hours of operation are:

• Sunday: 12:00-6:15 p.m.
• Monday: 9:30 a.m.-4:15 p.m.
• Tuesday: 9:30 a.m.-4:30 p.m.

For the most current information, visit  https://www.APHAPosters.com ~ APHA’s trusted partner for more than 15 years.

• What is public health
• Topics and Issues
• Policies and Advocacy
• Publications
• Professional Development
• Events and Meetings
• News and Media
• APHA Communities
• Privacy Policy

2024 © American Public Health Association

• CROI 2024 Important Dates and Deadlines
• CROI Foundation
• Scientific Program Committee
• Policies, Website, and Copyrights
• Funding and Grant Support
• Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
• Abstract Guidelines and Submission
• CROI 2024 Abstract Categories
• People-First Language and the Use of Appropriate Terminology
• Frequently Asked Questions
• Invited Presenters
• Themed Discussion Guidelines
• Oral Abstract Presentation Guidelines
• Letter Of Invitation (For Visa And Other Purposes)
• Who Can Attend
• Media Accreditation and Registration
• CROI 2024 List of Hotels
• Affiliated and Proximate Activities
• New Investigator Scholarship
• International Investigator Scholarship
• Community Educator and Mentor Scholarships
• CROI 2024 Preliminary Program
• CROI 2024 Resources
• Continuing Medical Education (CME)
• Resources From Prior Years
• Abstracts and ePoster Archive
• CROI Issues of TAM TM

Poster Presentation Guidelines

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of p oster a bstracts will be assi g ned to stand at their respective boards, organized by topic, on 1 of the 3 conference days. All p ost e rs will be available for viewing throughout the conference in the poster hall and in an electronic format in the conference m obile a pp ( access is restricted to registered CROI attendees only ).    

See Also: Important Dates | Abstract Submission | Oral Abstract Guidelines | Themed Discussion Guidelines | Registration | Embargo Policy | FAQs

Poster Presenter Responsibilities and Opportunities at CROI

Eposter upload.

Poster presenters are required to upload an ePoster (PDF file) version of their poster that will be available to attendees through the CROI Mobile App. The ePoster submission is now live, presenting authors will receive an email with their login credentials on February 22, 2024 with the subject “CROI 2024 ePoster is Open.”

ePoster Upload Instructions (Required) Deadline: February 29, 2024, at 8:00 AM PT.

• To upload your ePoster for the conference, log into your Speaker Portal using the login credentials provided in the email. The link to the speaker portal can be found here: CROI 2024 ePoster Upload Speaker Portal
• Select your poster presentation from the “My Sessions” section. This session will be designated by your poster number and title.
• Click on the “Documents” tab under the session information.
• Poster files can be replaced with a newer version until February 29, 2024, at 8:00 AM PT.

Poster presenting authors illustrate their study findings by displaying graphs, figures, diagrams, and text that describe their main background, methods, findings, results, and conclusions on posters presented during assigned sessions at CROI.  

CROI Poster Format

Posters should be designed to attract interested attendees by quickly focusing them on the study’s main findings.  

Poster presenters are strongly encouraged to use the CROI poster template, which can be accessed in a PowerPoint template here: CROI Poster Template (Download) . This poster format draws attendees to a poster and allows them to easily identify the main findings, according to our attendee feedback. The notes contain poster guidelines that include formatting notes (eg, font size, use of color, poster print size) and poster content requirements (eg, the addition of the assigned poster number and the policy against the use of QR codes).  

Feedback has shown that the preferred CROI Poster Format (above) is a more effective way to communicate key findings as well as supporting data. Download the Poster Template .

Poster Walks

The CROI Program Committee will host Poster Walks to discuss key science presented in poster sessions. Program committee members lead a small group of new investigators through these “poster walk-throughs” daily during the poster sessions. The committee members curate a list of poster presentations, hold a brief introductory discussion with the group, then lead them to visit each of the curated posters and encourage discussion with poster presenters. Following a short debrief, new investigators are encouraged to visit other poster presentations independently. 

Electronic Poster Theaters

The CROI Program Committee will introduce key science presented in poster sessions each day. Presentations will take place in 1 of 3 theaters designated for Basic Science, Clinical, and Epidemiology/Public Health. After these presentations, attendees will be better prepared to engage with the poster presenters during their designated poster session. 

Poster Sessions and Displaying Your Poster at CROI

• Posters should be on display for the entire conference and not removed before the end of the poster session on the last day of CROI
• Posters are assigned to a session with other poster presentations that share a similar theme and assigned to a day for presentation
• Poster presenters should stand by their poster for the full duration of their assigned session to discuss it and respond to questions from attendees

Poster presenters should make their travel plans for CROI keeping their session assignment in mind, as we cannot reassign posters to a different session. If exigent circumstances preclude the presenting author from attending the session, a replacement must be found to present the poster. As submitters agreed to in the submission process, all poster presenters must present their work at CROI. Any work that is accepted at CROI must be presented by the presenting author, or notification of replacement must be sent to [email protected] , prior to CROI. The inability of an author to present may impact all authors’ ability to present at CROI in the future.

Poster Contents

Poster Title: The poster title should be the same as the title submitted with the abstract and appear in boldface at the top in standard American Medical Association (AMA) title case. Nouns, pronouns, verbs, and other important words begin with uppercase letters; coordinating conjunctions, articles, and prepositions of 3 letters or fewer should all be in lowercase unless they are the first or last words in a title or subtitle.  

Assigned Poster Number: The assigned poster number should be displayed in the upper right corner (“0000” in the CROI Poster Format template). This is not the abstract submission number assigned during the submission of the abstract, but a number that denotes the position of the poster in the poster hall and in the conference program. This number is sent to the presenting author after late-breaking abstracts have been accepted.  

QR Codes and Links to External Materials Are Not Allowed: QR codes, bar codes, or other links to external resources are not permitted on posters displayed at CROI or on electronic versions of the posters to be uploaded to the CROI website.  

Corporate Logos and Trade Names: The use of commercial logos and trade names should not be used on posters, opening slides, title slides, or presentation slides.  

Displaying Posters at CROI

The suggested size for posters is either 54 inches (width) x 36 inches (height) or 60 inches x 40 inches (137.2 cm x 91.4 cm or 152.4 cm x 101.6 cm) based on the CROI Poster Template. The minimum size for a poster is 36 inches (width) x 24 inches (height) so attendees can see the poster at least 10 feet away. The size of the board for displaying the poster is 96 inches (width) x 48 inches (height), and the maximum size of a poster is 93 inches (width) x 45 inches (height).  

The face of the poster board is covered with Velcro-receptive fabric. Pushpins will be provided to hang posters. Posters can be set up on Sunday, March 3, between 12:00 PM and 6:00 PM local time, and on Monday, March 4, between 7:30 AM and 12:00 PM local time.  

Poster Printing

Presenting authors should print their physical poster based on the requirements listed in the sections above. CROI does not print posters on behalf of presenters. There are four FedEx Print Shops located around the Colorado Convention Center:

FedEx Office Print & Ship Center:  Open Weekends (0.6 miles; 10-minute walk)

1437 15th Street, Denver, CO 80202

+1 (303) 623-3500

Grand Hyatt Denver: Closed on Sundays (0.4 miles; 10-minute walk)

555 17th Street, Suite 190, Denver, CO 80202

+1 (303) 298-8610

FedEx Office:  Closed on Sundays (0.7 miles; 15-minute walk)

225 E 17th Avenue, Denver, CO 80203

+1 (303) 830-1981

Hyatt Regency Denver:  Closed on weekends (0.2 miles: 5-minute walk)

650 15th Street, Denver CO 80202

+1 (303) 534-2198

Guidelines for Presentation

Trade names.

Trade names for drugs should not be used in presentations. Refer to drugs and products by their nonproprietary names.  

Acknowledgments of Support and Contributors

Acknowledgments of support may be included in the poster presentation of the abstract at CROI.   

Sex Stratification and Other Demographic Variables

Presentations from randomized trials and cohorts should follow the ICMJE guidelines, including reporting of study designs (eg, prospective, observational, randomized, double-blind, STROBE, CONSORT, or others), statistical methods, and outcomes by demographic variables. For human clinical or epidemiologic studies, the presentation should provide sex-stratified results or identify who was included if it includes only a single population. Presentations of preclinical data including the use of cell lines and animal studies should include the sex of the animals or the sex of the source of the cell lines. If data are not available on sex (as assigned at birth) or gender (where gender is relevant to the study results), this should be identified as a limitation in the study.  

See: ICMJE Preparing for Submission  

Use of People-First Language and Appropriate Terminology  

See: Appropriate Terminology

Presentations Describing New Compounds  

Please be sure to include information sufficient to allow for meaningful review of compound data; this can include isolation, activity, chemical structure, mechanism of action, toxic effects, and pharmacologic data. The chemical or molecular structure must be shown in the presentation (it need not be part of the abstract or be published in the Abstract eBook).  

Publication or Presentation Prior to CROI

If study data are accepted for publication or presentation after the abstract submission to CROI, and that publication or presentation is expected to take place before CROI, the presenting author must contact CROI at [email protected] to provide details as soon as the presentation is accepted for review, presentation, or publication in another venue or outlet. Please be aware that although publication in these circumstances will not necessarily prevent presentation of the research at CROI, our strong preference is that any additional publication or presentation happen either simultaneous to or following presentation at CROI. Requests to publish or present research accepted for presentation at CROI prior to its presentation at CROI will be evaluated on a case-by-case basis. Failure to notify the conference promptly regarding plans to publish or present a CROI-accepted abstract prior to CROI may result in the removal of the study from the conference program.  

2023 Abstracts and Poster Presentations

NASP is pleased to present the publication peer-reviewed abstracts that are part of the  NASP 2023 Annual Meeting & Expo . NASP extends its heartfelt appreciation to the authors who are participating in the poster display of their work and are on hand to answer attendee questions to further expound on their research and results.

Publication

View all 2023 published abstracts in the Taylor & Francis MEDLINE-indexed journal Current Medical Research & Opinion (CMRO) .

Categories of abstracts submissions included:

• Specialty Pharmacy Outcomes & Practice-Based Research
• Specialty Pharmacy Products, Services, or Programs
• Digital Engagement/Technology in Specialty Pharmacy Services

Abstracts accepted for presentation at the NASP Annual Meeting & Expo must reflect completed research and are based on the following: novelty of the research, significance of the findings, relevance to specialty pharmacy, and clarity. Submission of previously presented research is permitted.

2023 Poster Winners

With NASP members serving as poster judges, award winners will be announced on Thursday, September 21 in the following categories:

• Specialty Pharmacy Outcomes & Practice-Based Research : “Maximizing Cost Savings: The Impact of Specialty Pharmacist Interventions at a Community Oncology Center.” Presenting author: Casey Fitzpatrick, PharmD, BCPS, CPS Solutions.
• Specialty Pharmacy Products, Services, or Programs : “Impact of Integrating a Pharmacy Liaison Managed Care Model within a Diabetes Population.” Presenting author: Lillian Piz, M.S., Shields Health Solutions – Berkshire Health Systems.
• Digital Engagement/Technology in Specialty Pharmacy Services : “Oral Oncology Adverse Event Reporting via Text Messaging Integrative Collaboration Between Specialty Pharmacy and Oncology Provider Clinic.” Presenting author: Kelly Mathews, PharmD, CSP, Optum Specialty Pharmacy.
• Attendee Choice : “Impact of Pharmacist Intervention on the Collection of Sustained Virologic Response Tests in Patients Treated for Hepatitis C at a Health-System Specialty Pharmacy.” Presenting author: Samantha Manson, PharmD, MBA, WVU Medicine – Allied Health Solutions Specialty Pharmacy.

To view abstract posters, please click on the abstract titles below.

CE home study credit is available for pharmacists attending the 2023 Annual Meeting & Expo. Please click here for instructions on how to claim CE.

1: Health system owned specialty pharmacy provided laboratory monitoring for patients with multiple sclerosis receiving sphingosine 1-phosphate receptor modulators

Authors:  Victoria McCarthy, PharmD, Jenna Stratman, PharmD, Carolyn Faylor, PharmD, Marco Pinto, BS, Anthony Donovan, PharmD

2: Impact of a Health System Specialty Pharmacy on Patient Engagement and Clinical Outcomes Post-Transition of Management  

Authors:  Casey Fitzpatrick, PharmD, BCPS; William G Waldron, RPh, MHA; Leigh Briscoe-Dwyer, PharmD, BCPS, FASH; Binoy Shah, PharmD, MBA; Fredrick Campogni, PharmD, BCMAS, 340B ACE, AAHIVP, CSP, DPLA; JessicaMourani, PharmD

3: A comprehensive approach to alleviate the pharmacy technician shortage and the implementation of a structured specialty pharmacy training program in a classroom setting

Authors:  Bisni Narayanan, PharmD, MS; Brittany Dasher, BS, CPhT; Eric V. Buchsbaum, CPhT; Terri Sue Rubino, PharmD, CSP; Vinay Sawant, RPh, MPH, MBA

4: Biosimilar Perceptions Among Autoimmune Prescribers and Pharmacists in Health System Specialty Pharmacy

Authors:  Jessica Mourani, PharmD; Carly Giavatto, PharmD; Casey Fitzpatrick, PharmD, BCPS; Adam Setter, PharmD; Larry Kobiska, PharmD,BS; Brandon Hardin, PharmD, MBA, CSP; Amber Skrtic, PharmD, CSP, AAHIVP; Amy Evans, PharmD, CSP; Eric Sredzinski, PharmD; SusanTrieu, PharmD; Ana I Lopez-Medina, PharmD

5: Education and evaluation strategies to implement a new care management documentation system in a health system specialty pharmacy

Authors: Sarah E. Wright, PharmD, BCACP; Kimhouy Tong, PharmD, BCPS; Robin D. Cullen, PharmD, MHA; Bisni Narayanan, PharmD, MS; Andrew Cadorette, PharmD; Eric V. Buchsbaum, CPhT; Esther Nowak, CPhT; Terri Sue Rubino, PharmD, CSP; Vinay Sawant, RPh, MPH, MBA

6: Opportunities Provided to Students through a Specialty Pharmacy Externship Program

Authors: Lauren Moy, BS, PharmD Candidate; Nehrin Khamo, PharmD, CSP; Michael Eagon, PharmD; Karen Thomas, PharmD, PhD, MBA

7: Optimizing initiation for self-injectable medications with remote demonstration kits delivered via specialty pharmacy

Authors:  Sean Glynn, Todd Greenwood, Yash Prajapati, Xinyu Xu, Tim McLeroy, Joe Reynolds

8. Smart Strategies for Control Room Temperature Shipping of Mail Order Specialty Pharmaceuticals

Authors: Anthony Alleva, BA; Chantal Walker, MESc, CTP Level II; Ryan Sanders; Kevin Kohleriter, MBA; Jordan Bonomo, BS, BA

9: Abemaciclib Linkage to Care: A Health System Specialty Pharmacy Initiative

Authors: Chasity Mosby, PharmD Candidate; Ana Lopez Medina, PharmD; Casey Fitzpatrick, PharmD, BCPS; Jessica Mourani, PharmD; Steven Fosnight, PharmD; Megan Rees, PharmD, BCACP, CSP; Amber Skrtic, PharmD, CSP, AAHIVP; Katie Jo Cash, PharmD, CSP; Carly Giavatto, PharmD

10: Achieving Accreditation of Health System Specialty Pharmacies Through a Standardized Method

Authors: Patrick Ryan, PharmD, BCCCP, Lauren Mills; Danielle Rand, PharmD; Kate Campagnola, PharmD

11: Alternate Work Arrangement within Specialty Pharmacy

Authors: Alijah Kosarko, BA, CPhT; Bisni Narayanan, Pharm D, MS; Mitchell DelVecchio, Pharm D, CSP; Heather McKeon, BSHCA; Terri Sue Rubino, Pharm D, CSP; Vinay Sawant, RPh, MPH, MBA 

12: Clinical Continuity Intervention for Newborns Exposed to Maternal HIV Infection

Authors: Aislinn Devoe, RN, MSN, CMSRN, CV-BC; Mark D’Ambrosi, RPh, CSP; Natalie Amendola BS, CPhT; Michele Riccardi, PharmD, BCPS; Nadia Yohannes, RPh; Tina Do, PharmD, MS, BCPS; Terri Sue Rubino, PharmD, CSP; Vinay Sawant, RPh, MPH, MBA

13: Expanding Patient Care Services to Solid Organ Transplant Patients by Establishing an Accredited Health System Specialty Pharmacy

Authors: Sonali Niyogi, PharmD, Shamsul Arif, PharmD, Marilyn Pitts, PharmD, BCPS

14: Impact of Integrating a Pharmacy Liaison-Managed Care Model within a Diabetes Population

Authors: David MacHaffie, RPh; Lillian Piz, MS; Nicholas Bull, PharmD; Shreevidya Periyasamy, MSHIA, Martha Stutsky, PharmD

15: Implementation of ambulatory clinical pharmacist type 2 diabetes care services within an integrated health-system specialty pharmacy

Authors: Sharon Zhu, PharmD; Veronica Sozio, PharmD, BCPS; Rachel Quinn, PharmD, BCACP, AE-C; Kathleen Horan, PharmD, BCACP; Kate Smullen, PharmD, MSCS; Martha Stutsky, PharmD, BCPS; Ameet Wattamwar, PharmD; Kenny Yu, PharmD, MBA, ACE

16: Pharmacy Integration into the Fertility Service Line: University Hospitals Specialty Pharmacy

Authors:  Catherine N Seeco, PharmD; Alayna Manalo, CPhT; Allene Naples, PharmD, MBA, CSP

17: Respiratory Syncytial Virus (RSV) Protection: A Pan-Pharmacy Approach

Authors:  Carrie Gatzke, PharmD, CSP; Jenny Carr, APRN, NNP-BC; Jessy Thomas, PharmD, MBA; and Morgan Osborn, PharmD

18: Addressing Social Determinants of Health: A Health System Specialty Pharmacy Initiative

Authors:  Carly Giavatto, PharmD; Jacob Deisenroth BS, CPhT; Casey Fitzpatrick, PharmD, BCPS; Jessica Mourani, PharmD; Ana Lopez Medina, PharmD

19: Business Development Team Enhances Clinical Continuity by Leveraging Health System Partners

Authors: Tina Do, PharmD, MS, BCPS; Aislinn Devoe, MSN, CMSRN; Mark D’Ambrosi, RPh, CSP; Natalie Amendola, CPhT; Victoria Lucero, PharmD; Kimhouy Tong, PharmD, BCPS; Vinay Sawant, RPh, MPH, MBA

20: Developing a disease state specific patient management program at an integrated health system specialty pharmacy

Authors: Michele Riccardi, PharmD, BCPS; Kimhouy Tong, PharmD, BCPS; Todd Cooperman, PharmD, MBA; Sarah Wright, PharmD, BCACP; Terri Sue Rubino, PharmD, CSP; Tina Do, PharmD, MS, BCPS; Vinay Sawant, RPh, MPH, MBA

21: Effectiveness of Patient Navigation in Resolving Health-System Related Barriers to Care for Patients with Bleeding Disorders

Authors: Justin Lindhorst, MBA; Shelby Smoak Ph.D; Bill Wilbert; Brenda King; Kimberly Epps PharmD, CSP

23: Treatment patterns of intravenous edaravone in patients with amyotrophic lateral sclerosis: A retrospective administrative claims analysis

Authors:  Malgorzata Ciepielewska, MS; Emma Richard, MPH; Yaoxuan Xia, MS; Hiangkiat Tan, MS, BPharm

24: Impact of a Clinical Pharmacist-Led Care Program on Patients with Hemophilia A, UtilizingTherigySTM

Authors:  Lily Duong, PharmD, RPh; Khang Tran, PharmD, RPh; Abbas Dewji, PharmD, RPh, CSP; Catlin Goodfriend, PharmD, RPh; Jessica Mourani, PharmD; Casey Fitzpatrick, PharmD, BCPS; Carly Giavatto, PharmD

25: Application of PROs and PROMS as Interventions

Authors: Penny Surratt, BSN, RN, MBA; Sarah Kester, PharmD, RPh; Sulisa Chow, PharmD, RPh, MBA

26: Adherence and Discontinuation of Prescription Cannabidiol for the Management of Seizure Disorders at an Integrated Care Center

Authors:  Paige Barnes, PharmD Candidate; Holly Dial, PharmD; Josh DeClercq, MS; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Kayla Johnson, PharmD, BCPS, BCPP

27: Adherence patterns in rheumatoid arthritis patients receiving a Janus Kinase (JAK) inhibitor or a Tumor Necrosis Factor a inhibitor after the addition of a black box warning to JAK inhibitors

Authors: W. Cliff Rutter, PharmD, PhD; Kunal Patel, PharmD; Samantha Delgado, PharmD, MS; Guy Cozzi, PharmD, CSP; Elisea Avalos-Reyes, PhD; Will Cavers, MS; Chen Liu; Rashmi Grover, PharmD; Lucia Feczko, RPh; Kjel Johnson, PharmD

28: Influence of seasonal changes on adherence in Rheumatoid Arthritis patients

Authors: Cody Schmidt, PhD-C; Kunal Patel, PharmD; Samantha Delgado, PharmD, MS; Guy Cozzi, PharmD, CSP; Elisea Avalos-Reyes, PhD; W. Cliff Rutter, PharmD, PhD; Rashmi Grover, PharmD; Lucia Feczko, RPh; Will Cavers, MSc; Kjel Johnson, PharmD

29: Clinical Outcomes Associated With Prescription Cannabidiol Use At 12-Months Post-Initiation

Authors:  Kayla Johnson, PharmD, BCPS, BCPP; Paige Barnes, PharmD Candidate; Holly Dial, PharmD Candidate; Wendi Owens, CPhT; Josh DeClercq, MS; Leena Choi, PhD; Nisha B. Shah, PharmD; Shilpa Reddy, MD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP

30: Clinical Outcomes in Rheumatoid Arthritis Patients Enrolled in an Integrated Specialty Pharmacy Care Model

Authors:  Carolkim Huynh, PharmD; Shreevidya Periyasamy, MS HIA; Kate Smullen, PharmD; Martha Stutsky, PharmD

31: Evaluating Patient-Reported Adherence and Outcomes in Specialty Disease States: A Dual Site Initiative

Authors:  Chelsea P. Renfro, E. Danielle Bryan, Rebekah H. Anguiano, Lisa Kumor, Lauren Moy, Josh DeClercq, Leena Choi, Autumn D. Zuckerman

32: Evaluation of Inflammatory Bowel Disease Treatment Discontinuation Rates in Patients within Health System Specialty Pharmacy

Authors: Janese Bibbs, PharmD Candidate 2024; Katie Jo Cash, PharmD, CSP; Amy Evans, PharmD, CSP; Toni Zahorian, PharmD, BCACP; Amber Skrtic, PharmD, CSP, AAHIVP; Casey Fitzpatrick, PharmD, BCPS; Ana Lopez Medina, PharmD; Jessica Mourani PharmD; Carly Giavatto, PharmD

33: Hidden in plain sight: A data-driven approach to identifying patients earlier in their Alpha-1 antitrypsin deficiency diagnostic odyssey

Authors: Adam Reyna, PharmD; Jay Bryant-Wimp, RPh; Miranda Morrison, MBA, MPP

34: Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network

Authors: Martha Stutsky, PharmD; Dale Fasching, PharmD, MBA; Diana Miller; Laura West’ Carolkim Huynh, PharmD; Christopher Barr; Jennifer L. Donovan, PharmD

35: Impact of an Integrated Health System Specialty Pharmacy on HIV Clinical Outcomes

Authors:  Elizabeth Maloy, PharmD, BCACP, CSP; Angelo Jones, PharmD, BCPS; Shreevidya Periyasamy, MS, HIA; Y. Caleb Chun, MA; Christopher Barr, Amy Riggs, PharmD, MBA, CSP; Jeremy Spires, PharmD; Jim Schwamburger, BS Pharm, MBA; Martha Stutsky, PharmD, BCPS

36: Impact of Health System Specialty Pharmacy Management on Clinical Outcomes in Patients with Asthma

Authors: Casey Fitzpatrick, PharmD, BCPS; Nicholas D’Angelo, PharmD, CSP, MSCS; Anthony Zuppelli, PharmD, CSP;Ryan VanSice, PharmD, BCPS, CSP; Ashley Blaakman, PharmD, CSP; Lauren Bryant, PharmD, CDCES; Jessica Mourani, PharmD; Nicole Griffith, PharmD, BCPS, AAHIVP

37: Impact of social determinants of health on multiple sclerosis adherence and persistence for patients using a national mail-order specialty pharmacy

Authors: Mona Modi, PharmD; Lauren Lawler, PharmD, CSP; Clarisse Purvis, PhD; Marwa Noureldin, PharmD, PhD, MS, BCGP; Kelly Mathews, PharmD, CSP

38: Impact of Specialty Pharmacy Implementation on Disease Burden and Quality of Life in Pediatric and Young Adult Patients Living with HIV

Authors: Tiffany M. Nason, PharmD; Susan D. Carr, PharmD; Timothy J. Howze, PharmD; Steve M. Pate, DPh; Joseph N. Sciasci, PharmD; Adejumoke Shofoluwe PharmD; Jacob B. Goss, BS; Najwa I. Stewart, BS; Nehali Patel MD

39: Adherence Rates of Sphingosine-1-Phosphate Receptor Modulators in Patients with Multiple Sclerosis

Authors: Slava Kachar, PharmD; Cliff Rutter, PharmD, PhD; Elisea Avalos-Reyes, PhD; Kelly McAuliff, PharmD; Rashmi Grover, PharmD; Lucia Feczko, RPh; Chen Liu, PhD; Dorothea Verbrugge, MD; Kjel Johnson, PharmD

40: Concomitant Apalutamide and Relugolix in Patients With High-Risk Localized Prostate Cancer: Testosterone Suppression 1-Year Update

Authors: Gordon Brown; Laurence Belkoff; Jason Hafron; Pankaj Aggarwal; Rushikesh Potdar; Amitabha Bhaumik; Jennifer Phillips; Tracy McGowan; Neal Shore

41: Multiple Switching Between the Biosimilar Adalimumab PF-06410293 and High-Concentration Reference Adalimumab in Combination With Methotrexate in Patients With Moderately to Severely Active Rheumatoid Arthritis

Authors:  Mark Latymer, Daniel F Alvarez, Donna S Cox, Karen Wang, Wuyan Zhang

42: Patient-Oriented Eczema Measure (POEM) Scores to MeasurePatient Improvement with Specialty Medication for Atopic Dermatitis

Authors:  Dana Simonson, PharmD, BCPS; Ann McNamara, PharmD; Ann Harty, PharmD; Alicia Zagel PhD, MPH 

43: Real-world use of immunomodulators in patients receiving pegloticase for chronic gout

Authors:  Christine Miller, PharmD; Drew Doyle, RPh; Barbara Prosser, RPh

44: Safety of Deutetrabenazine Above Food and Drug Administration Maximum Recommended Dose in Huntington’s Disease Chorea 

Authors: Kayla Dodson, PharmD Candidate; Sabrina Livezey, PharmD, CSP; Kayla Johnson, PharmD, BCPS, BCPP; Josh DeClercq, MS; Autumn Zuckerman, PharmD, BCPS, CSP

45: Analyzing Data for Specialty Conditions Such as Hepatitis-C

Authors: Richard A Brook, MS, MBA; Ian A Beren, BS; Nathan L Kleinman, PhD; Eric M. Rosenberg, MA

46: COST ANALYSIS OF ONCE DAILY EXTENDED-RELEASE TACROLIMUS (LCPT) AND TWICE DAILY IMMEDIATE-RELEASE TACROLIMUS (IR-TAC) FOR KIDNEY TRANSPLANT PATIENTS

Authors:  Keren Rodriguez, PHARMD, CSP; Chris Hayes, PHARMD; Rachel Chelewski, PHARMD, CSP; Autumn Zuckerman, PHARMD, BCPS, AAHIVP, CSP; Bridget Lynch, PHARMD; Ryan P Moore, MS; Jake Bell, BS, CPHT; Katie Cruchelow, PHD

47: FINANCIAL IMPACT OF INTEGRATED SPECIALTY PHARMACY EFFORTS TO AVOID ORAL ONCOLYTIC WASTE

Authors:  Brooke D. Looney, PharmD, CSP; Jared Crumb, PharmD; Gabrielle Jones, PharmD candidate; Ryan Moore, MS; Leena Choi, PhD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Kristen Whelchel, PharmD, CSP

48: Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies

Authors:  Chelsey Lindner, PharmD, BCOP, CSP; Y. Caleb Chun, MA; Shreevidya Periyasamy, MS, HIA; Christopher Barr; Dale Fasching, PharmD, MBA; Martha Stutsky, PharmD, BCPS

49: Maximizing Cost Savings: The Impact of Specialty Pharmacist Interventions at a Community Oncology Center

Authors:  Megan Rees, PharmD, BCACP, CSP; Carly Giavatto, PharmD; Ana Lopez Medina, PharmD; Jessica Mourani, PharmD; Casey Fitzpatrick, PharmD, BCPS

50: RETRAINING OF TRANSPLANT PHARMACY STAFF TO REDUCE MEDICARE PART B PRESCRIPTION BILLING ERRORS IN POST-TRANSPLANT RECIPIENTS

Authors:  Carey Vallone, CPhT;Sarah Osman, CPhT-Adv; KirstenMitchell, CPhT-Adv; Michael Wilson, CPhT; Chelsea Ray,CPhT; Keren Rodriguez, PharmD, CSP; Chris Hayes, PharmD; Rachel Chelewski, PharmD, CSP; Genevieve Staff, PharmD; Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP; Brianna Hawkins, MBA, PharmD Candidate, 2023; Katie Cruchelow, PhD

51: Rheumatoid Arthritis (RA) and non-infused biologics: adherence, healthcare cost and utilization

Authors: Staskon, F., PhD; Witt, E.A., PhD; Baiano, R., PharmD, CSP

52: Positive Impact of a Specialty Pharmacy Health Coach Program

Authors: Dana Simonson, PharmD, BCPS; Ann McNamara, PharmD; Holly Wiest, MA; Ann Harty, PharmD; Alicia Zagel PhD, MPH 

53: A Comparison of Face-to-Face vs. Virtual Educational Nursing Support on Patient Compliance with Oral and Inhaled PAH Therapies

Authors:  Evangelia Sourounis, PharmD, W. Cliff Rutter, PharmD, PhD, Elisea Avalos-Reyes, PhD, Frank Billick, BSN, RN, CRNI; Rashmi Grover, PharmD, Lucia Feczko, RPh and Kjel Johnson, PharmD

54: A model for medication therapy management service implementation in a health system specialty pharmacy

Authors:  Athena Peterson, PharmD; Lauren Schwartz, PharmD, MBA; Bisni Narayanan, PharmD, MS; Terri Sue Rubino, PharmD, CSP; Vinay Sawant, MPH, MBA

55: Development and Implementation of Collaborative Pharmacy Practice Agreements in an Integrated Health System Specialty Pharmacy: A Qualitative Analysis

Authors:  Chelsea P. Renfro, PharmD, CHSE; Katie H. Cruchelow, PhD; Matt Phillips, PharmD, MBA; Amy Mitchell, PharmD, CSP; Autumn D. Zuckerman, PharmD, BCPS, CSP

56: Disease Therapy Management for Medication Adherence in Rheumatoid Arthritis

Authors:  Kyle Osborne, PharmD, BCPS, CSP; Gregory B Russell, MS; Nicole Cowgill, PharmD, BCOP, CSP, DPLA; Henry Chow, MD, CCD

57: Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacy

Authors:  Nhi Bui, PharmD; Michaela Wachal, PharmD, CSP; Thomas Huynh, PharmD, CSP; Martha Stutsky, PharmD, BCPS

59: Impact of Pharmacist Intervention on the Collection of Sustained Virologic Response (SVR) Tests in Patients Treated for Hepatitis C at a Health-System Specialty Pharmacy

Authors: Samantha Manson, PharmD, MBA; Evan Turco, PharmD, BCPS; Kelsi Conant, PharmD, CSP; Rachel Mitchell, PharmD, BCPS, CSP

60: A Health System Specialty Pharmacy-led check-in Protocol in Patients on Oral Oncolytics

Authors:  Amanda K. Cooper, PharmD; Khang Tran, PharmD; Lily Duong, PharmD; Abbas Dewji, PharmD, CSP; Carly Giavatto, PharmD; Casey Fitzpatrick, PharmD, BCPS; Jessica Mourani, PharmD, CSP; Jennifer Craig, PharmD, CSP; Reem AlQazzaz, PharmD, CSP

61: Achieving Quality Pharmacy Care for HIV Post Exposure Prophylaxis (PEP) Therapy

Authors: J. Cerulli, A. Harris, D. Morse, S. Przybyla, J. Cullen, A. Roberts, S. Guisinger, C. Cerulli

62: Clinical and Quality Outcomes of a Hypertrophic Cardiomyopathy Management Program within an Integrated Health System Specialty Pharmacy Model

Authors:  Veronica Sozio, PharmD, BCPS; Martha Stutsky, PharmD, BCPS; Kerry Mello-Parker, PharmD, MBA; Robin Anderton, RN, MSN; Kate Smullen, PharmD, MSCS, Tatyana Cohen, PharmD, AE-C, IgCP; Shreevidya Periyasamy, MS, HIA; Ameet Wattamwar, PharmD; Kenny Yu, PharmD, MBA, ACE 

63: Impact of PROMIS-10 on health-related quality-of-life outcomes in specialty pharmacy settings

Authors: Khang Tran, PharmD;Lily Duong, PharmD; Abbas Dewji, PharmD, CSP; Carly Giavatto, PharmD; Casey Fitzpatrick, PharmD, BCPS; Jessica Mourani, PharmD

64: Measuring prescription turnaround times in an integrated health system specialty pharmacy setting

Authors: Geri Buderwitz MBA, PharmD, Leandra Battisti PharmD, Benjamin Mohr MHA

65: Utilization of standard half-life or extended half-life products in members with Hemophilia A prescribed Hemlibra

Authors: Natalie Watkins, PharmD; Cliff Rutter, PharmD, PhD; Elisea Avalos-Reyes, PhD; Kelly McAuliff, PharmD; Chen Liu, PhD; Rashmi Grover, PharmD; Lucia Feczko, RPh; Dorothea Verbrugge, MD; Kjel Johnson, PharmD

66: Adherence to biologic therapies in patients with Ulcerative Colitis and Crohn’s disease: Analysis of a national specialty pharmacy and the MarketScan commercial claims database

Authors: Junlan Zhoua, Edward A. Witta, Mallory Schmolla

67: Difference in persistence between tablets and capsules

Authors:  Shehla Zaidi, PharmD; Cliff Rutter, PharmD, PhD; Elisea Avalos-Reyes, PhD; Dipti Shah, PharmD, CSP; Kelly McAuliff, PharmD, BCOP, CSP; Rashmi Grover, PharmD; Lucia Feczko, RPh; Chen Liu, PhD; Emily Kipping, MA, MBA; Kjel Johnson, PharmD

68: Evaluating prior authorization turnaround times for integrated health system specialty pharmacy patients

Authors: Benjamin Mohr MHA, Geri Buderwitz MBA PharmD, Leandra Battisti PharmD

69: Impact of clinical dashboards for data capture and reporting across health system specialty pharmacies

Authors: Carson Kantoris, PharmD Candidate; Ana Lopez Medina, PharmD; Carly Giavatto, PharmD; Jessica Mourani, PharmD; Amber Skrtic, PharmD, CSP, AAHIVP; Hector Mayol Torres, BSEE; Erica Rosa, MPH;Casey Fitzpatrick, PharmD, BCPS 

70: Individualized Care Plans’ Effect on Therapy Adherence for Patients Prescribed Olaparib

Authors: Yoona Kim, PharmD, PhD; Denise Tran, PharmD; Jordon Rabey, MS; Elaine Murphy, BS; Benjamin Matherne, MBA; Daniel Weaver, BSN, RN

71: Technology-Driven Delivery Performance, using predictive insight to take action…before shipping is even initiated

Author: Sebastian Pistritto, MBA

72: Development of a Workflow to Manage Non-specialty Medications at a Specialty Pharmacy 

Authors:  Mitchell DelVecchio, PharmD, CSP, Francesca Amici, PharmD, John Fitzgerald, PharmD, Alexandra Gianazza, PharmD, BCGP, NataliaKrupski, PharmD, Terri Sue Rubino, PharmD, CPS

73: Identifying Medication Access Barriers for Rare and Complex Disease Patients within the Pharmacy Hub Space

Authors: Luke Gross, PharmD; Kathleen Dawson, PharmD, MBA; Rami Chammas, PharmD, MPBA; Douglas Gebhard, PharmD, MBA; Kyle Davis, BA, MCTSDM; Gordon Vanscoy, PharmD, MBA, CACP

74: A landscape assessment of digital engagement with healthcare decision-makers

Authors: Joanna Ng; Jasmine Knight; Tasmina Hydery; Laurie Fazio

75: Implementation of a new patient case management system at a large health system specialty pharmacy

Authors: Kimhouy Tong, PharmD, BCPS; Terri Sue Rubino, PharmD; Andrew Cadorette, PharmD; Michele Riccardi, PharmD, BCPS; Sarah E. Wright, PharmD; BCACP; Vincent Do, PharmD, BCPS, BCTXP; Vinay Sawant, RPh, MBA

76: Optimize Your Patient Services to Support the Patient Treatment Journey

Authors: James Battaglia, John Giannouris, Stuart Kamin, Devansh Sheth

77: Oral oncology adverse event reporting via text messaging integrative collaboration between specialty pharmacy and oncology provider clinic

Authors: Meagan Pawlak, PharmD; Jessica Vinckier, PharmD CSP; Lauren Lawler, PharmD, CSP; Helen Kim, PharmD, BCGP; Jessica Lynton, PharmD, BCPS; Marwa Noureldin, PharmD, PhD, MS, BCGP; Kelly Mathews, PharmD, CSP

78: IMPACT OF MULTI-STEP ORDER TRANSMITTAL IN AN INFLAMMATORY BOWEL DISEASE CLINIC

Authors:  Caroline Hammond, PharmD; Alyssa Stewart, PharmD, BCACP, CSP, CPP; Kathy Bricker, PharmD, BCPS, DPLA; Jennifer Young, PharmD, BCPS, CSP; Kyle Hansen, PharmD, MS, BCPS, CSP

79: High Patient Engagement with a Pharmacy-Created Digital Refill Program

Authors: Katie Moore, PharmD, CSP; Clint Ivie, PharmD, MBA, CSP

80: Improving Medication Adherence Documentation for Specialty Pharmacy Patients

Authors: Hayley O’Rourke, PharmD, CSP, Kaitlin Ciaramitaro, PharmD, MHA, CSP, Ryan H. Lackey, PharmD

81: The Implementation of Agile Methodology and its Impact on the Healthcare and Pharmacy Technology Industry

Authors: Samuel Aronson, PharmD; Kathleen Dawson, PharmD, MBA; Rami Chammas, PharmD, MPBA; Douglas Gebhard, PharmD, MBA; Gordon Vanscoy, PharmD, MBA, CACP 

• Mission and Values
• Constitution
• Strategic Plan
• Annual Reports
• Quarterly Update
• General Assembly
• Regional Standing Committees
• Working Groups
• Secretariat
• Full Members
• Associate Members
• Become a Member
• QA Networks
• INQAAHE Talks
• Conferences and Fora
• Upcoming Events
• Past Events
• International Standards and Guidelines for QA in TE (ISGs)
• Guidelines of Good Practice (GGP)
• GGP Aligned Agencies
• INQAAHE Funding Scheme (IFS)
• Calls for Proposals
• About the MPL Center
• Online Learning Center
• Best practices
• QA Graduate Program
• Webinar repository
• Community Conversations
• News from Secretariat
• News from Members
• Query Services
• Visual Guide

• [email protected]'s blog

Conference 2023 poster presentations

Inqaahe conference 2023 roadmap to enabling quality in tertiary education 2030, may 29 - june 1, 2023, poster presentations, the greening of quality assurance and institutional accreditation .

Presented by Dr. Scott G. Blair, Director of Accreditation and Quality Assurance at AIAASC, Vice President of CANIE-Europe, and Affiliate at the Gateway International Group, LLC.

Greening the standards of institutional accreditation would provide colleges, universities, and business schools with the motivation they currently lack to address the climate crisis head-on. As such, this poster presents a research-based overview of the “greenness” of the most prevalent accreditation standards used in IHE today. It textually deconstructs accreditation standards, rates their eco-sensitivity, and provides carrots and sticks for strengthening accrediting bodies in line with the SDGs and education for sustainable development.

Independent assessment of education quality as a tool of external quality assurance of higher education in Russia

Presented by Dr Mikhail Petropavlovskiy, The National Accreditation Agency (NAA), Russia.

An independent assessment of education quality through Internet technologies based on assessment materials developed by the leading Russian universities was conducted in Russia in 2021 and 2022. The idea is that based on the assessment tools (developed by the Russian’s leading universities for assessing their students’ general professional competencies) to form generalized task banks and use them to evaluate relevant degree programs in other universities.

In 2021, a collection was made for 8 different degree programs, in 2022 – for 6 programs. The assignments selected by the experts were converted and used to fill a Unified Bank of Assessment Tools (UBAT).

Testing of students from Russian HEIs was carried out using an information system based on the Internet technologies.

Testing revealed that the knowledge level of students from the universities participating in the project complied with the Federal State Educational Standard (FSES). Simultaneously with testing, a students’ questionnaire survey in terms of students’ satisfaction with the content of study programs was conducted. Based on the survey results a high level of students’ satisfaction with study programs is determined.

Quality Assurance for Simulation-Based Medical Education in a remote setting in Rwanda

Presented by Ornella Masimbi, The University of Global Health Equity, Rwanda.

The University of Global Health Equity (UGHE) provides health professions education in a deeply remote setting of Rwanda, some 200 km from the capital city, with the goal of producing physicians who can improve health service delivery and act as change agents. Simulation-based medical education (SBME) proven to enhance clinical competence andpatient safety, is not common in East Africa, but at the UGHE,it has been implemented and integrated across all years of physician’s training.We describe our approach to quality assurance for SBME in this low-incomesetting.

Building a common conceptual framework for safeguarding and quality assurance in higher education

Presented by Deborah Fletcher and Tomlin Paul, The University of Global Health Equity, Rwanda.

Safeguarding concerns itself with protecting health, well-being, and human rights of individuals at risk enabling them to live safely, free from abuse and neglect. Ideally, safeguarding should be a well-established responsibility for higher education institutions (HEIs); however, universities worldwide have faced several safeguarding related challenges. This safe environment is achieved through the collective effort of individuals, groups, and the organization itself (the micro, meso and macro). For HEI’s to roll-out effective safeguarding they must go through the psychosocial processes of “intuiting, interpreting, integrating and institutionalizing”, the 4I’s.

Using the 4I’s framework, small changes take place as individuals process intuition and interpreting, while radical changes take place as they take collective actions through integration. By linking a theory of change for safeguarding with the 4I’s framework the authors critically consider the role the three levels (micro, meso and macro) play in effecting change.

If looked at as having an institutional goal to reduce risks and vulnerabilities, then quality assurance can be applied at the three levels, with its scope visualised to include inter alia safeguarding. Safeguarding, if similarly applied, could achieve a range of outcomes for which quality assurance is used to ensure that processes are followed, and standards maintained. There is therefore a dualistic relationship between safeguarding and quality assurance. This perspective of the 4Is operating at the three levels is a fitting context for applying safeguarding and quality assurance as essential institutional change agents. The authors suggest that HEIs should explore this synergy to enhance quality outcomes.

The development of a quality assurance system (QAS) as an innovative practice for strengthening tertiary education

Presented by Dr. Marisabel FIGUEROA and MSc Humberto LEON, Quality Assurance Directorate, Bernardo O'Higgins University, Chile.

Organisational dynamics and changes in the environment promote the need for rapid adaptation, and tertiary education institutions do not escape this reality, so that the quality assurance mechanisms implemented by them require greater systematisation to ensure compliance with the criteria, standards, values, regulations and procedures established, while also safeguarding the legal aspects that regulate universities and tertiary education.

The development of a process structure and its correct interrelation facilitates the management not only of quality, but also of other relevant organisational aspects. The articulation in a single system of the main processes and resources existing in the institutions makes it possible to consider and develop aspects such as leadership, culture, organisational design, principles and values, among others.

Quality assurance activities depend on the existence of the necessary institutional mechanisms, preferably underpinned by a strong quality culture, to provide assurance and accountability in the promotion of shared values and the development of innovative practices in times of rapid change and disruption of all kinds.

The poster presented highlights the importance of the process approach in a university and its contribution to strengthening tertiary education, shared values and innovative practices. This is amply demonstrated by the recognition granted to the SAC model, developed by the Universidad Bernardo O'Higgins in Chile, which since 2021 is patented under the concept of innovation patent and registered at the European Patent Office (EPO) and World Intellectual Property Organization (WIPO) (AU 2021105723).

Small but mighty: micro-credentials are extensive for the future of work

Presented by Muhammad Hasfarizal Kamaludin, Head of Public and International Affairs Unit, Malaysian Qualifications Agency (MQA).

The COVID-19 global pandemic has caused massive disruptions in many sectors of society including higher education. The outbreak has caused Higher Education Institutions (HEIs) and the Malaysian Qualifications Agency (MQA) to embrace online learning and online assessment due to the Movement Control Order (MCO). This paper presents the impacts and benefits of Micro-Credentials for the future of work from the findings of two enablers; which is the HEIs which act as the providers and the industries which act as the requesters. This supply to demand relationship between HEIs and industries are further supported by the policy and framework under MQA and Ministry of Higher Education (MoHE) Malaysia.

Quality Assurance for Flexible Learners: Experiences and Expectations

Presented by Dr. B S Ponmudiraj, Adviser,  National Assessment and Accreditation Council (NAAC), India.

Needless mention the process of Assessment and Accreditation as a product of External Quality Assurance (EQA) Agency. In the Indian experience of quality of flexible learning pathways is of two ways, viz., capturing the essence of flexibility in the form of horizontal and vertical mobility of students, secondly multiple entry and multiple exit options for the learners. The National Assessment and Accreditation Council (NAAC) as a premier flagship EQA Agency of Indian Higher Education system being serving the society for the last 29 years in the form of Assessment and Accreditation of Institutions of Higher Learning in India has accredited over 9200 Higher Education Institutions (HEIs) in India. The quality assurance issues with respect to flexible pathways of learning environment in the Universities and Colleges revolve around technology and usage of technology.

Embrancing the use of technology in police training pursuant to sustainable development goal in securing and widening equitable access to quality assured training and supporting life-long learning

Presented by Ms. Carmen CHIK, Superintendent of Police, Hong Kong Police College, Hong Kong Police Force.

Practicality, timeliness and outcome-based are crucial in police training. The Hong Kong Police College (Police College) of the Hong Kong Police Force develops quality assurance (QA) from external accreditation to the current internal accreditation by building its institutional capability which is recognized by the statutory accreditation authority – Hong Kong Council for Accreditation of Academic and Vocational Qualifications (HKCAAVQ). To this end, Police College has initiated two interactive QA gatekeepers – Quality Assurance Mechanism and Internal Learning Programme Accreditation System. Facing a range of challenges, like pandemics, Police College embraces digitalization in its teaching and learning to incorporate into a blended approach without compromising quality aiming to provide inclusive and equitable training to all members of the organization and foster a potential platform for flexible life-long learning opportunities for all.

Insights into the OAAAQA practices: into further fostering the INQAAHE's values

Presented by Mr. Moez Marrouchi, National College of Automotive Technology (NCAT), Oman.

While studying the practices of the Oman Authority for Academic Accreditation (OAAA), now changed to be the Oman Authority for Academic Accreditation and Quality Assurance of Education (OAAAQA), with regard to Higher Education Institutions’ (HEIs) accreditations in Oman, to make a clear contribution to the literature of quality assurance in general and academic accreditation in Oman in particular, this study aims at revealing how this sole accrediting body’s practices promote the INQAAHE’s values. Based on nonnumerical data, where the literature about accreditation and observation are largely involved, the presenter gives a thorough overview of the current accreditation system and analyzes the roles being played by the OAAA, now called OAAAQA, in disseminating and fostering the culture of quality assurance among the HEIs as well as accrediting them. The presentation concludes that the OAAAQA mechanisms culminate in promoting the values of inclusiveness, integrity, independence, academic freedom, collaboration, internationalization, and diversity.

The University of Global Health Equity, Rwanda partnering on Roadmap 2030 for quality in health professions education

Presented by Tomlin Paul and Abebe Bekele, University of Global Health Equity.

The University of Global Health Equity (UGHE), Rwanda is an educational initiative started in 2015 in the a remote district, with the objective “to strengthen health systems and radically change the way health care is delivered around the world by training global health professionals to deliver more equitable, quality health services for all.” UGHE’s flagship programs the Master of Science in Global Health Delivery (MGHD) and the Bachelor of Medicine; Bachelor of Surgery/Masters in Global Health Delivery (MB BS/MGHD) have successfully leveraged over forty partnerships across academia, public and private sector for successful delivery. In 2022, UGHE received the ASPIRE-to-Excellence Award for its "Inspirational Approaches to Health Professions Education" from the Association for Medical Education of Europe (AMEE). This recognition is based on work in place-based health professions education promoting innovative pedagogy and a mutually rewarding community engagement. The overall educational approach follows principles consistent with UNESCO’s 2030 roadmap.

The right of quality assurance in Chilean universities through strategic direction and management models

Presented by Claudio Ruff Escobar, Bernardo O'Higgins University rector.

The heterogeneity of the education system involves a series of challenges when developing quality assurance mechanisms involving both government and private agencies.

In 2007, University Bernardo O'Higgins (UBO) participated in the accreditation process led by the National Accreditation Commission, motivated by its commitment to quality education as a right (along with the right to access higher education). Since then, UBO has developed a quality assurance system based on a Strategic Direction Model and its application in institutional management. From the application of these models, UBO positioned itself in international rankings that measure quality in higher education.

This proposal aims to present the Strategic Direction Model created by the government of UBO, which is observed through its positioning in international rankings. Furthermore, this proposal seeks to critically examine the management and quality assurance mechanisms in Latin America and the world so that improvements can be incorporated into the models developed.

Measuring students' critical thinking mindset and reasoning skills at an American-style university

Presented by Dr. Hayfa Jafar, Director Institutional Effectiveness, American University of Iraq-Sulaimani.

The importance of critical thinking (CT) is echoed by educators, employers, policy makers, and accreditation and quality assurance bodies, which emphasize the need to measure the learning outcomes related to these skills. Echoing this idea, our in-progress study uses a mixed methods, case study approach to assess the development of critical thinking and reasoning skills among students studying at an American-style university located in Kurdistan Iraq. To inform the interpretation of the assessment results, students and faculties’ perception of critical thinking will be investigated through in-depth interviews conducted in the spring semester of the academic year 2022-2023. This study is an exploratory one and uses the standardized test approach along with the above-mentioned interviews to assess the development of critical thinking and the factors that contribute to or hinder this process. Since the university adopts a liberal arts philosophy, this project is critical to ensuring the fulfilment of the university’s mission to cultivate students’ critical thinking skills.

Developing a robust internal quality assurance system: Small Island Developing State challenges and dilemmas

Presented by Dr Mohamed Shareef, (Vice-Chancellor), Aishath Shaheen Ismail, (Deputy Vice-Chancellor -Academic Affairs) and Dr Aminath Shiyama, Quality Assurance Controller, The Maldives National University (MNU), Maldives.

In the Maldives, a Small Island Developing State, The Maldives National University (MNU), is the largest and the first public university. While at MNU we face numerous challenges associated with the smallness of the country, over the recent years our commitment to quality assurance in higher education has intensified. The evolution of MNU 50 years ago, by coalescing various discipline-based institutes in the country gave MNU a unique fusion of various quality assurance processes which up until recently has not been made explicit nor harmonised.

In this presentation we will share how MNU with its history and distinguished standing in the country organised itself in developing an internal quality assurance framework. This process has enabled the development of a robust quality assurance culture especially one where students’ voices are at the forefront demonstrating MNU’s values for inclusivity and collaboration of all our stakeholders in the process.

Institutional audits in South African Higher Education: 2021-2022

Presented by Drs. Britta Zawada, Sanele Nene, Bongiwe Hobololo and Precious Sipuka, Council on Higher Education, South Africa.

The Council on Higher Education (CHE) in South Africa was legislated into being after the dawn of democracy in South Africa by the Higher Education Act (Act No. 101 of 1997, as amended) with a variety of mandates, roles and responsibilities with its role confirmed through the National Qualifications Framework (NQF) Act (Act No. 67 of 2008, as amended). In this session, the focus will be on the institutional audits of public universities that took place in 2021 and 2022. The first presentation sketches an outline of the institutional audits and reports on survey questionnaires that were conducted. The second presentation explores one of the themes that emerged during the audits, namely the career development trajectories of academic staff in public universities in South Africa. The third presentation explores a second theme, namely the issue of staff wellness during the pandemic that emerged from the institutional audit process.

Quality Assurance Issues & Practices in Higher Education Institutions in India with special reference to National Assessment and Accreditation Council (NAAC) accredited institutions

Presented by Dr. Ruchi Tripathi, National Assessment and Accreditation Council (NAAC), India and Dr. B S Ponmudiraj, Adviser, NAAC, India.

Quality assurance is paramount important for maintaining the quality of higher education institutions. This paper focuses on quality assurance aspects, the core areas of functions and activities of higher education institutions. An innovative and relevant framework has been designed by Indian accreditation agencies National Assessment and Accreditation Council (NAAC) which serves the basis of quality indicators which helps in getting employment/selfemployment/entrepreneurship for the students of higher education institutions. Indian institutions are assessed and accredited based on seven criteria related to curricular aspects, teaching learning and evaluation, research innovation and extension, infrastructure and learning resources, student support and progression, governance leadership and management, and institutional values and best practices. The data collected by NAAC for higher education institutions based on responses provided by the institutions have been taken into account for analysis purpose. The analysis has been carried out separately for universities and colleges, region and state wise. 

Transformation of tertiary education: role of QAS in formation and enhancing students innovative's competencies

Presented by Nadezda Abbas, UBO, Chile.

Nowadays we live in fast changing society where not only learning and training have become vitally important, but an ability to innovate as well. That innovative competence is demanded by the labour market, the public, state and the employees themselves, and the education system recognizes its importance and plays a central role in the development of innovative skills. However, some modern studies show that higher education institutions cannot meet these requirements. In these circumstances the role of internal quality assurance system has risen significantly. One of the main tasks of modern higher education is to create conditions for the formation of innovative competencies among young people. Innovative competencies presuppose the development of an adequate attitude to innovation, to a situation of uncertainty, the ability to react quickly in such conditions and make competent decisions ahead of time. The topic highlights QAS contribution in formation of innovative competity. 

INQAAHE Conference 2023 is sponsored by  KazMunayGas , a platinum sponsor, the  Education & Training Evaluation Commission (ETEC) , a gold sponsor,  Astana Development , a bronze sponsor, and  Kazakh Tourism .

GO to www.nationalperinatal.org

POSTER PRESENTATIONS

Congratulations to our 2023 poster award winners: .

Research Award

Engaging a lived experience advisory group in the evaluation of maternal telehealth access project during the covid-19 pandemic, deitre epps, ms     courtnie carter, ba, cchw     maya jackson, models of care award, trauma-informed and resilience-promoting care in the perinatal settings, agustina bertone, phd     sierra kuzava, phd karolina grotkowski, phd     catherine mogil, psyd, maternal postpartum care in pregnancies complicated by fetal congenital anomalies, preliminary validation of a new family psychosocial risk measure in the nicu - the pat-nicu-cicu.

Maternal-Fetal Surgery in the Dobbs Era: Ethical Principles Inform Clinical Practice to Protect Pregnant Patients

Development and evaluation of a virtual postpartum psychosocial support program based upon act, maternal attitudes, adjustment, health behaviors, and social support among mothers of infants in the nicu, a single institution neuroprotection and developmental care quality improvement initiative, effects of timing of birth and pandemic related experiences on mother-infant bonding during covid, dream big: addressing early childhood mental health and social determinants of health in neurologic neonatal follow-up clinic, leveraging a user-friendly approach to develop mommaconnect :  mobile therapy application for mothers with postpartum depression and their infants, mobile applications used for perinatal mental health: consumer perspective, the effects of pharmacological interventions caring for neonates with nas, cultivating trauma-informed care in the nicu: barriers and facilitators to implementation, the importance of nicu discharge planning guidelines , a multi-tiered systemic approach to helping families thrive in the nicu and beyond, psychological distress in nicu providers: a scoping review in progress, therapeutic approaches to working with perinatal loss clients: a grounded theory study, the need for parental support following prenatal genetic testing, recognizing and working with medical trauma in the perinatal period: a multidisciplinary approach, postpartum menstrual equity: video analysis of vaginal bleeding information, care planning, and pads offered to new parents during the childbirth hospitalization, cultural competemility and professionalism: an innovative approach to enhancing culturally sensitive equitable perinatal care , h.a.t.c.h.: helping all to come home, raising awareness about perinatal mental health through film: reflections from drexel university npass’s documentary screening event, effects of family-centered care versus mobile-enhanced family integrated care on preterm infant and maternal outcomes: a quasi-experimental, time-lagged study, virtual reality technology as a stress inoculation tool for nicu caregivers, progress update from mother baby connections, an intensive outpatient program for perinatal women in philadelphia.

We are grateful to our presenters for sharing their research.

Please take a moment to show your appreciation and share your insights., you may find a new partner and ally., 2023 poster presentations.

Leah B. Sodowick, B.A.

Alison r. hartman, m.s., chavis a. patterson, ph.d., pamela a. geller, ph.d. , psychological distress in neonatal intensive care unit providers: a scoping review in progress.

Hisham Nsier

Sodowick, l., saxton,  s.n., steinwurtzel, r., shivers, m., andersen, m., patterson, c..

Denise Marion B. Paed

Katelyn m. phan, leah b. sodowick, ba, pamela a. geller, phd.

Dr. Christy Gliniak, PhD, OTR/L, CNT, CPXP

Dr. jenene craig, phd, mba, otr/l, cnt, dr. georgeanna robinson, edd, dr. deanna gibbs, phd, mot, gcresmeth, bappsc(ot), cnt.

Vincent C. Smith, MD, MPH

Kristy love, erika goyer, ba.

Sister Paula Ude (SJS), DSW, LMSW

Linda S. Franck, PhD, RN

Caryl l. gay, phd, thomas j. hoffman, phd, rebecca m. kriz, ms, rn, robin bisgaard, ms, rn, diana m. cormier, dnp, rn, priscilla joe, md, brittany lothe, ma, yao sun, phd, md.

Sharon Ettinger

Margaret h. kyle, morgan firestein, maha hussain ​, jennifer barbosa, vanessa babineau, dani dumitriu, catherine monk.

Elizabeth Fischer, PhD

Amy heffelfinger, phd, jennifer koop olsta, phd, katherine carlton, md, lauren miller, phd, samuel adams, md, stacy stibb, md, andrew foy, md, susan cohen, md.

Emily Hunter

Jessica beneway, maria priyma, ms, june andrews horowitz, phd, rn, pmhcns-bc, faan, bobbie   posmontier, phd, cnm, pmhnp-bc, faan, tony ma, ms.

Alexa Bonacquisti, PhD, PMH-C

Julia milliken, tori abdalla, begum slayyeh, alexandra keresztesy, elizabeth becks, ma, maternal attitudes, adjustment, health behaviors, and social support among mothers of infants in the neonatal intensive care unit.

Ryanne Schaad, MS

Elizabeth greco, chloe hriso, chavis a. patterson, phd, shannon hanson, phd, mph.

Peggy Burke, B.S.

Pamela a. geller, ph.d., john chuo, m.d., m.p.h., kirthika parmeswaran, chavispatterson, ph.d..

Kristin P. Tully, PhD

Shilpa m. darivemula, md  (video abstract), alison m. stuebe, md, msc, kelley e.c. massengale, phd, mph.

Agustina Bertone, PhD

Sierra kuzava, phd, karolina grotkowski, phd, catherine mogil, psyd.

2023 Models of Care

Ruth Elgren PT, DPT

L. conradt phd, l. liszka otd, otr/l, k. athavale md, m. cotten md.

Heather Olivier, LPC, PMH-C, CCTP, NCC

Victoria Rodriguez, LPC, CCTP, NCC

Ayesha Bhatia, MPH

Peggy maclean, phd, chelsey wilhite, phd.

Immie Gillgrass

Jasmine graham, ph.d..

Amy E. Baughcum, PhD

Olivia e. clark, ma, stephen lassen, phd, christine a. fort ney, phd, rn, chavis patterson, phd, cynthia a. gerhardt, phd.

Leveraging a User-Friendly Approach to Develop MommaConnect: Mobile Therapy Application for Mothers with Postpartum Depression and their Infants

Bobbie Posmontier, PhD, CNM, PMHNP-BC, FAAN

Mona elgohail, phd, katie chang, ms, mary mcdonough, phd, rn, c-em, kayla alvares, ms, phd candidate.

Deitre Epps, MS 

Courtnie carter, ba, cchw, maya jackson, 2023 research.

Rachel L. Bank

Madeline mckenna, jane corteville, emily hamburg-shields.

C. Chase Binion, BS

Divya mallampati, md, mph, mary faith marshall, phd, hec-c, anne lyerly, md, ma.

Pamela A. Geller

Leah sodowick, bobbie posmontier, june horowitz, effects of childhood & adulthood social determinants of health on psychological stress in pregnancy.

2022 RESEARCH AWARD

Shelby alsup, hannah dugoni, olivia doyle, alice graham, kristen mackiewicz seghete, forging perinatal mental health support in an early pediatric healthcare system.

2022 INNOVATIVE MODELS of CARE AWARD

Erin m. sadler, psyd, pmh-c , anna koozmin, msw, lgsw, caroline van buskirk, ba, sasha zients, ba, carol chace, msw, licsw, lcsw-c, lamia soghier, md faap, chse, lenore jarvis, md, med, ololade okito, md faap, sofia perazzo, md, michael lee, ba.

Poster presentation instructions

Prepare your poster

Poster presenters will interact with conference participants in two ways:

• Attend and present a printed poster at the meeting (each poster presenter must bring a printed version of their poster)
• Upload a poster PDF for publication. Poster PDFs will be available for on-demand viewing in the online program during the conference and will be published and archived with the manuscript after the meeting in the conference proceedings on the SPIE Digital Library.

Instructions on preparing your poster presentation and publishing your poster PDF are below.

Important dates

*Contact author or speaker must register prior to uploading **After this date slides must be uploaded onsite at Speaker Check-in

Poster schedule

Poster Location : Moscone Center, Room 2003 (Level 2 West)

Review poster session times and details per conference

Step-by-step guide to a successful poster presentation

Create and print your poster

The most successful posters are graphically rich presentations of your research that highlight and summarize the main points, with the poster presenter filling in the details in person at the session. The least effective poster format is an enlarged copy of your manuscript.

Your poster should include:

• The paper title and all authors at the top of the poster
• A brief introduction, goals, experimental detail, conclusions, and references; presented in a logical and clear sequence
• Explanations for each graph, picture, and table

Size, fonts, and color

• The maximum poster size is 44” x 44” (112cm x 112cm). View the SPIE Poster template
• Title: 36 point type
• List of authors: 25 point type
• Body copy should be double-spaced text: 15 point type
• Choose your colors to provide strong contrast and avoid pairing red and green elements to assist those with red-green color blindness

Print a high-resolution copy of your poster to present onsite (size must not exceed 44" x 44" [112 cm x 112 cm]).

Create and submit your poster PDF

Poster presentations can be created in a number of software applications but must be exported to PDF format to submit for publication in the conference proceedings in the SPIE Digital Library. The PDF file size must be less than 100 MB. Avoid uploading multiple versions of your poster PDF. When you finish creating your PDF, check the following:

• Is your poster PDF saved with the .pdf file extension?
• Is your file size less than 100 MB?
• Do all your graphs, pictures, and tables include explanations?
• Is your text color and size easy to read on screen?
• Did you include references?

Submit your poster PDF

Your poster PDF must be received by the deadline, approximately 3 weeks before the meeting. After the submission system opens for presentations and manuscripts, using any web browser, visit https://spie.org/myaccount and sign into your account.

• From the account dashboard, look under "Submission and Review System" and click on the symposium link
• Scroll down until you find your paper
• Click on the upload poster file link to submit your poster PDF and follow the steps to upload your .pdf file

NOTE: The contact author or speaker must be registered before uploading. Only the contact author can submit the poster PDF. The contact author can assign a coauthor as the contact author via the submission system or by sending a request to [email protected] (include your paper number in the message).

Set up your poster in person

• Bring your high-resolution printed poster with you to the meeting (size must not exceed 44" x 44" [112 cm x 112 cm])
• Check the individual conference program to find your poster session location and timing
• Set up your printed poster at least one hour before your session start time on the day you are scheduled to present
• Paper numbers will be placed on the poster boards in numerical order
• Find your paper number and put up your printed poster in the designated space
• Push pins, tape, or Velcro will be provided to hang your poster

Present your poster in person

• Each poster presenter is responsible for printing their poster and bringing it to the meeting. SPIE does not print the posters.
• Each poster must have a unique presenter; one person may not present more than one poster
• Poster presenters are required to stand by the poster during the scheduled duration of the poster session to answer questions from attendees
• Presenters who have not placed their poster(s) on their assigned board at least 60 minutes prior to the start of the poster session, and attend to it for the duration of the poster session, will be considered a "no show," and their manuscript and poster PDF will not be published in the proceedings on the SPIE Digital Library
• Presenters must remove their printed posters immediately after the poster session
• SPIE assumes no responsibility for the printed posters and will not save posters left hanging after the end of the session.

Publication of your poster

• SPIE will publish and archive all poster PDFs along with the manuscript in the conference proceedings in the SPIE Digital Library
• To qualify for publication, poster PDFs must be received by the advertised due dates, and the printed poster must be presented at the meeting
• SPIE retains rights to distribute and market the published poster PDF; the presenter retains copyright of all presented content

Contact your program coordinator (listed in your SPIE.org account )

TERMIS-EU 2023

Poster Presentations

Posters at the TERMIS EU 2023 meeting will be presented in person as  paper posters .

They will appear on poster boards in the poster area to be viewed by conference participants during two poster sessions.

POSTER PRESENTATION LIST

To view the poster presentatıon list please click here .

POSTER PRESENTATION GUIDELINES

• Posters should be prepared in  portrait A0 format : 1189 mm (46.8 inches) Height and 841 mm (33.1 inches) Width.
• All the material necessary for attaching the poster to the poster board is available at the posters’ help desk in the respective poster area.
• Authors are responsible for setting up and removing their posters.
• Abstract title, author(s) and affiliation(s) should appear on top of the poster.
• Please make sure that your poster can be read easily from a distance of 2 meters.
• All posters must be written entirely in English.
• Posters should be displayed on the assigned days. 

POSTER Set-Up, Presentation and Dismantle

Set-Up, Presentation and Dismantle Schedule:  Posters have been assigned to one of the below poster sessions.

POSTER SESSION 1:

POSTER SESSION 2:

NeurIPS 2024, the Thirty-eighth Annual Conference on Neural Information Processing Systems, will be held at the Vancouver Convention Center

Monday Dec 9 through Sunday Dec 15. Monday is an industry expo.

Registration

Pricing » Registration 2024 Registration Cancellation Policy » . Certificate of Attendance

Our Hotel Reservation page is currently under construction and will be released shortly. NeurIPS has contracted Hotel guest rooms for the Conference at group pricing, requiring reservations only through this page. Please do not make room reservations through any other channel, as it only impedes us from putting on the best Conference for you. We thank you for your assistance in helping us protect the NeurIPS conference.

Announcements

• To help faciliate visa applications, Canadian immigration has asked that for those of you who need visa that you give us your visa application ID after you apply.  If you need a Canadian visa: 1) Register 2) Generate an Invitation Letter  3) Apply for a visa  4) Return to the Invitation Letter page and fill out the form on the lower part of the page.

Latest NeurIPS Blog Entries [ All Entries ]

Important dates.

If you have questions about supporting the conference, please contact us .

Become an 2024 Exhibitor Exhibitor Info »

Organizing Committee

Workflow manager, logistics and it, mission statement.

The Neural Information Processing Systems Foundation is a non-profit corporation whose purpose is to foster the exchange of research advances in Artificial Intelligence and Machine Learning, principally by hosting an annual interdisciplinary academic conference with the highest ethical standards for a diverse and inclusive community.

About the Conference

The conference was founded in 1987 and is now a multi-track interdisciplinary annual meeting that includes invited talks, demonstrations, symposia, and oral and poster presentations of refereed papers. Along with the conference is a professional exposition focusing on machine learning in practice, a series of tutorials, and topical workshops that provide a less formal setting for the exchange of ideas.

More about the Neural Information Processing Systems foundation »

Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements:  Google Chrome 24+ ,  Mozilla Firefox 20+ ,  Internet Explorer 11 ,  Opera 15–18 ,  Apple Safari 7 ,  SeaMonkey 2.15-2.23

• Meeting Calendar
• OncologyPRO
• Past Meetings

European Lung Cancer Congress 2024

You will be able to download and print your certificate of attendance upon completion of the online evaluation questionnaire form., certificate of attendance, follow these 3 steps to obtain your certificate of attendance:.

• Login with your ESMO username and password
• Complete the evaluation questionnaire and click submit
• The system will download your certificate

Please contact  [email protected]  if you have any questions.

Photo Gallery

Meeting resources.

Abstracts and ePosters are open access. Presentations  (slides) and  webcasts are available to  ESMO Members and registered delegates according to the presenters' agreement to release them.

ESMO Events App

Create your own personalised agenda and browse the scientific programme by day, topic, cancer type and track with the  ESMO events app .

Download now

Video Gallery

#elcc24: global experts on why you should submit your work to this important lung cancer event, #elcc24: co-chairs paul baas & natasha leighl on why you should submit your abstract, #elcc24: co-chairs paul baas & natasha leighl on why you should attend, #elcc24: reasons why you should attend, daily reporter.

The ESMO Daily Reporter is the official ESMO newspaper providing live reporting, highlights, critical insights on data presented at ESMO congresses, and expert opinions on controversial topics.

Read the ESMO Daily Reporter

The ELCC 2024 programme is now online!

Download and print your Certificate of Attendance upon completion of the online evaluation questionnaire form

The ELCC 2024 abstract submission is now closed

Information for Presenters

Find here instructions to assist with your presentation

Congress Officers

Find out more about the partners of ELCC 2024

Information about the Exhibition

Industry Participation

Industry partners: find out how to get involved

Industry Sponsored Satellite Symposia

Esmo colloquia.

The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community

The ELCC 2024 will take place at the Prague Congress Centre in Prague, Czech Republic.

Accommodation

Kuoni Tumlare Congress has been appointed as official housing agency for the ELCC 2024

Press & Media

Information for media representatives

Health and Safety

Find out more about the regulations to access the congress

Contact information for the event organisers

Social Media

Follow #ELCC24​ on Facebook, Twitter, LinkedIn, Instagram and YouTube

Practical Information

Frequently Asked Questions

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy .

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.